REGENXBIO, Inc. (RGNX)
7.20
+0.02
(+0.28%)
USD |
NASDAQ |
Nov 20, 15:09
REGENXBIO 30-Day Average Daily Volume : 1.248M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.248M |
| November 18, 2026 | 1.296M |
| November 17, 2026 | 1.306M |
| November 16, 2026 | 1.313M |
| November 13, 2026 | 1.361M |
| November 12, 2026 | 1.372M |
| November 11, 2026 | 1.386M |
| November 10, 2026 | 1.384M |
| November 09, 2026 | 1.417M |
| November 06, 2026 | 1.389M |
| November 05, 2026 | 1.392M |
| November 04, 2026 | 1.387M |
| November 03, 2026 | 1.380M |
| November 02, 2026 | 1.392M |
| October 30, 2026 | 1.395M |
| October 29, 2026 | 1.472M |
| October 28, 2026 | 1.498M |
| October 27, 2026 | 1.472M |
| October 26, 2026 | 1.479M |
| October 23, 2026 | 1.469M |
| October 22, 2026 | 1.455M |
| October 21, 2026 | 1.457M |
| October 20, 2026 | 1.472M |
| October 19, 2026 | 1.461M |
| October 16, 2026 | 1.454M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.441M |
| October 14, 2026 | 1.429M |
| October 13, 2026 | 1.403M |
| October 12, 2026 | 1.411M |
| October 09, 2026 | 1.402M |
| October 08, 2026 | 1.404M |
| October 07, 2026 | 1.367M |
| October 06, 2026 | 1.392M |
| October 05, 2026 | 1.535M |
| October 02, 2026 | 1.490M |
| October 01, 2026 | 1.487M |
| September 30, 2026 | 1.468M |
| September 29, 2026 | 1.430M |
| September 28, 2026 | 1.394M |
| September 25, 2026 | 1.377M |
| September 24, 2026 | 1.361M |
| September 23, 2026 | 1.340M |
| September 22, 2026 | 1.332M |
| September 21, 2026 | 1.325M |
| September 18, 2026 | 1.334M |
| September 17, 2026 | 1.280M |
| September 16, 2026 | 1.271M |
| September 15, 2026 | 1.262M |
| September 14, 2026 | 1.242M |
| September 11, 2026 | 1.251M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 5.258M |
| Anika Therapeutics, Inc. | 118570.5 |
| United Therapeutics Corp. | 543109.4 |
| Biomea Fusion, Inc. | 2.109M |
| ACADIA Pharmaceuticals, Inc. | 2.367M |